Business Context and Reporting Period
Company: CorMedix Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 17, 2017
Reporting Period: Quarter and year ended December 31, 2016
This filing serves as a notification that the company issued a press release on March 17, 2017, announcing its financial results for the specified period. The press release is attached as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only indicates that such results were announced in the referenced press release.
Guidance, Outlook, and Risks
The text contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It explicitly states that the information in Item 2.02 (including the press release) is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 17, 2017) for actual financial figures.
- Verify the specific revenue, net income, and cash flow numbers for the quarter and year ended December 31, 2016.
- Check for any forward-looking statements or guidance included in the press release.
- Confirm the company's liquidity position and debt obligations as detailed in the full press release.